Human Injection Flu Vaccine Market, Global Outlook and Forecast 2022-2028
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report contains market size and forecasts of Human Injection Flu Vaccine in global, including the following market information:
Global Human Injection Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Injection Flu Vaccine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Human Injection Flu Vaccine companies in 2021 (%)
The global Human Injection Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Injection Flu Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Injection Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Injection Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Human Injection Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Human Injection Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Human Injection Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Human Injection Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Injection Flu Vaccine revenues share in global market, 2021 (%)
Key companies Human Injection Flu Vaccine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Human Injection Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Human Injection Flu Vaccine in global, including the following market information:
Global Human Injection Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Injection Flu Vaccine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Human Injection Flu Vaccine companies in 2021 (%)
The global Human Injection Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Injection Flu Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Injection Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Injection Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Human Injection Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
Global Human Injection Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
- 6 Months to 3 Years
- > 3 Years
Global Human Injection Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Human Injection Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Injection Flu Vaccine revenues share in global market, 2021 (%)
Key companies Human Injection Flu Vaccine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Human Injection Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Jiangsu GDK
- KM Biologics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Human Injection Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Injection Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN INJECTION FLU VACCINE OVERALL MARKET SIZE
2.1 Global Human Injection Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Human Injection Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Injection Flu Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Injection Flu Vaccine Players in Global Market
3.2 Top Global Human Injection Flu Vaccine Companies Ranked by Revenue
3.3 Global Human Injection Flu Vaccine Revenue by Companies
3.4 Global Human Injection Flu Vaccine Sales by Companies
3.5 Global Human Injection Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Injection Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Injection Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Injection Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Injection Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Injection Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Human Injection Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Injection Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Human Injection Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Human Injection Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Injection Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Human Injection Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Injection Flu Vaccine Market Size, 2021 & 2028
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application - Global Human Injection Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Injection Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Human Injection Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Human Injection Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Injection Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Human Injection Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Injection Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Human Injection Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Injection Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Human Injection Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Human Injection Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Injection Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Human Injection Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Injection Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Human Injection Flu Vaccine Sales, 2017-2028
6.4.3 US Human Injection Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Human Injection Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Human Injection Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Injection Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Human Injection Flu Vaccine Sales, 2017-2028
6.5.3 Germany Human Injection Flu Vaccine Market Size, 2017-2028
6.5.4 France Human Injection Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Human Injection Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Human Injection Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Human Injection Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Human Injection Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Human Injection Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Injection Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Human Injection Flu Vaccine Sales, 2017-2028
6.6.3 China Human Injection Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Human Injection Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Human Injection Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Human Injection Flu Vaccine Market Size, 2017-2028
6.6.7 India Human Injection Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Injection Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Human Injection Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Human Injection Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Human Injection Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Injection Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Human Injection Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Human Injection Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Human Injection Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Human Injection Flu Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Human Injection Flu Vaccine Major Product Offerings
7.1.4 Sanofi Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Injection Flu Vaccine Major Product Offerings
7.2.4 CSL Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CSL Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Human Injection Flu Vaccine Major Product Offerings
7.3.4 GSK Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Viatris
7.4.1 Viatris Corporate Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Human Injection Flu Vaccine Major Product Offerings
7.4.4 Viatris Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Viatris Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Human Injection Flu Vaccine Major Product Offerings
7.5.4 AstraZeneca Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Hualan Bio
7.6.1 Hualan Bio Corporate Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Human Injection Flu Vaccine Major Product Offerings
7.6.4 Hualan Bio Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Hualan Bio Key News
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Corporate Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Major Product Offerings
7.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Changchun Institute of Biological Key News
7.8 Sinovac
7.8.1 Sinovac Corporate Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Human Injection Flu Vaccine Major Product Offerings
7.8.4 Sinovac Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Sinovac Key News
7.9 Jiangsu GDK
7.9.1 Jiangsu GDK Corporate Summary
7.9.2 Jiangsu GDK Business Overview
7.9.3 Jiangsu GDK Human Injection Flu Vaccine Major Product Offerings
7.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Jiangsu GDK Key News
7.10 KM Biologics
7.10.1 KM Biologics Corporate Summary
7.10.2 KM Biologics Business Overview
7.10.3 KM Biologics Human Injection Flu Vaccine Major Product Offerings
7.10.4 KM Biologics Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 KM Biologics Key News
8 GLOBAL HUMAN INJECTION FLU VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Injection Flu Vaccine Production Capacity, 2017-2028
8.2 Human Injection Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Injection Flu Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN INJECTION FLU VACCINE SUPPLY CHAIN ANALYSIS
10.1 Human Injection Flu Vaccine Industry Value Chain
10.2 Human Injection Flu Vaccine Upstream Market
10.3 Human Injection Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Injection Flu Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Human Injection Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Injection Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN INJECTION FLU VACCINE OVERALL MARKET SIZE
2.1 Global Human Injection Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Human Injection Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Injection Flu Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Injection Flu Vaccine Players in Global Market
3.2 Top Global Human Injection Flu Vaccine Companies Ranked by Revenue
3.3 Global Human Injection Flu Vaccine Revenue by Companies
3.4 Global Human Injection Flu Vaccine Sales by Companies
3.5 Global Human Injection Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Injection Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Injection Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Injection Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Injection Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Injection Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Human Injection Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Injection Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Human Injection Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Human Injection Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Injection Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Human Injection Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Injection Flu Vaccine Market Size, 2021 & 2028
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application - Global Human Injection Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Injection Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Human Injection Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Human Injection Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Injection Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Human Injection Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Injection Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Human Injection Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Injection Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Human Injection Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Human Injection Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Injection Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Human Injection Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Injection Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Human Injection Flu Vaccine Sales, 2017-2028
6.4.3 US Human Injection Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Human Injection Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Human Injection Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Injection Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Human Injection Flu Vaccine Sales, 2017-2028
6.5.3 Germany Human Injection Flu Vaccine Market Size, 2017-2028
6.5.4 France Human Injection Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Human Injection Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Human Injection Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Human Injection Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Human Injection Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Human Injection Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Injection Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Human Injection Flu Vaccine Sales, 2017-2028
6.6.3 China Human Injection Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Human Injection Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Human Injection Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Human Injection Flu Vaccine Market Size, 2017-2028
6.6.7 India Human Injection Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Injection Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Human Injection Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Human Injection Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Human Injection Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Injection Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Human Injection Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Human Injection Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Human Injection Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Human Injection Flu Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Human Injection Flu Vaccine Major Product Offerings
7.1.4 Sanofi Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Injection Flu Vaccine Major Product Offerings
7.2.4 CSL Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CSL Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Human Injection Flu Vaccine Major Product Offerings
7.3.4 GSK Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Viatris
7.4.1 Viatris Corporate Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Human Injection Flu Vaccine Major Product Offerings
7.4.4 Viatris Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Viatris Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Human Injection Flu Vaccine Major Product Offerings
7.5.4 AstraZeneca Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Hualan Bio
7.6.1 Hualan Bio Corporate Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Human Injection Flu Vaccine Major Product Offerings
7.6.4 Hualan Bio Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Hualan Bio Key News
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Corporate Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Major Product Offerings
7.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Changchun Institute of Biological Key News
7.8 Sinovac
7.8.1 Sinovac Corporate Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Human Injection Flu Vaccine Major Product Offerings
7.8.4 Sinovac Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Sinovac Key News
7.9 Jiangsu GDK
7.9.1 Jiangsu GDK Corporate Summary
7.9.2 Jiangsu GDK Business Overview
7.9.3 Jiangsu GDK Human Injection Flu Vaccine Major Product Offerings
7.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Jiangsu GDK Key News
7.10 KM Biologics
7.10.1 KM Biologics Corporate Summary
7.10.2 KM Biologics Business Overview
7.10.3 KM Biologics Human Injection Flu Vaccine Major Product Offerings
7.10.4 KM Biologics Human Injection Flu Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 KM Biologics Key News
8 GLOBAL HUMAN INJECTION FLU VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Injection Flu Vaccine Production Capacity, 2017-2028
8.2 Human Injection Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Injection Flu Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN INJECTION FLU VACCINE SUPPLY CHAIN ANALYSIS
10.1 Human Injection Flu Vaccine Industry Value Chain
10.2 Human Injection Flu Vaccine Upstream Market
10.3 Human Injection Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Injection Flu Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Human Injection Flu Vaccine in Global Market
Table 2. Top Human Injection Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Injection Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Injection Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Human Injection Flu Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Human Injection Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Injection Flu Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Injection Flu Vaccine Product Type
Table 9. List of Global Tier 1 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Human Injection Flu Vaccine Product Offerings
Table 48. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Human Injection Flu Vaccine Product Offerings
Table 51. CSL Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Human Injection Flu Vaccine Product Offerings
Table 54. GSK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Human Injection Flu Vaccine Product Offerings
Table 57. Viatris Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Human Injection Flu Vaccine Product Offerings
Table 60. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Hualan Bio Corporate Summary
Table 62. Hualan Bio Human Injection Flu Vaccine Product Offerings
Table 63. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Changchun Institute of Biological Corporate Summary
Table 65. Changchun Institute of Biological Human Injection Flu Vaccine Product Offerings
Table 66. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sinovac Corporate Summary
Table 68. Sinovac Human Injection Flu Vaccine Product Offerings
Table 69. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Jiangsu GDK Corporate Summary
Table 71. Jiangsu GDK Human Injection Flu Vaccine Product Offerings
Table 72. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. KM Biologics Corporate Summary
Table 74. KM Biologics Human Injection Flu Vaccine Product Offerings
Table 75. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Human Injection Flu Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Human Injection Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Human Injection Flu Vaccine Production by Region, 2017-2022 (Units)
Table 79. Global Human Injection Flu Vaccine Production by Region, 2023-2028 (Units)
Table 80. Human Injection Flu Vaccine Market Opportunities & Trends in Global Market
Table 81. Human Injection Flu Vaccine Market Drivers in Global Market
Table 82. Human Injection Flu Vaccine Market Restraints in Global Market
Table 83. Human Injection Flu Vaccine Raw Materials
Table 84. Human Injection Flu Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Human Injection Flu Vaccine Downstream
Table 86. Human Injection Flu Vaccine Downstream Clients in Global Market
Table 87. Human Injection Flu Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Human Injection Flu Vaccine in Global Market
Table 2. Top Human Injection Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Injection Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Injection Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Human Injection Flu Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Human Injection Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Injection Flu Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Injection Flu Vaccine Product Type
Table 9. List of Global Tier 1 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Injection Flu Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Human Injection Flu Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Human Injection Flu Vaccine Product Offerings
Table 48. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CSL Corporate Summary
Table 50. CSL Human Injection Flu Vaccine Product Offerings
Table 51. CSL Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Human Injection Flu Vaccine Product Offerings
Table 54. GSK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Viatris Corporate Summary
Table 56. Viatris Human Injection Flu Vaccine Product Offerings
Table 57. Viatris Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Human Injection Flu Vaccine Product Offerings
Table 60. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Hualan Bio Corporate Summary
Table 62. Hualan Bio Human Injection Flu Vaccine Product Offerings
Table 63. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Changchun Institute of Biological Corporate Summary
Table 65. Changchun Institute of Biological Human Injection Flu Vaccine Product Offerings
Table 66. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sinovac Corporate Summary
Table 68. Sinovac Human Injection Flu Vaccine Product Offerings
Table 69. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Jiangsu GDK Corporate Summary
Table 71. Jiangsu GDK Human Injection Flu Vaccine Product Offerings
Table 72. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. KM Biologics Corporate Summary
Table 74. KM Biologics Human Injection Flu Vaccine Product Offerings
Table 75. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Human Injection Flu Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Human Injection Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Human Injection Flu Vaccine Production by Region, 2017-2022 (Units)
Table 79. Global Human Injection Flu Vaccine Production by Region, 2023-2028 (Units)
Table 80. Human Injection Flu Vaccine Market Opportunities & Trends in Global Market
Table 81. Human Injection Flu Vaccine Market Drivers in Global Market
Table 82. Human Injection Flu Vaccine Market Restraints in Global Market
Table 83. Human Injection Flu Vaccine Raw Materials
Table 84. Human Injection Flu Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Human Injection Flu Vaccine Downstream
Table 86. Human Injection Flu Vaccine Downstream Clients in Global Market
Table 87. Human Injection Flu Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Human Injection Flu Vaccine Segment by Type
Figure 2. Human Injection Flu Vaccine Segment by Application
Figure 3. Global Human Injection Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Injection Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Injection Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Injection Flu Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Injection Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Injection Flu Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Injection Flu Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Injection Flu Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Human Injection Flu Vaccine by Region, 2021 VS 2028
Figure 50. Human Injection Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Human Injection Flu Vaccine Segment by Type
Figure 2. Human Injection Flu Vaccine Segment by Application
Figure 3. Global Human Injection Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Injection Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Injection Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Injection Flu Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Injection Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Injection Flu Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Injection Flu Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Injection Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Injection Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Injection Flu Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Human Injection Flu Vaccine by Region, 2021 VS 2028
Figure 50. Human Injection Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels
